Reactive oxygen species-responsive theranostic nanoparticles for enhanced hypoxic tumor photodynamic therapy via synchronous HIF-1α inhibition and ATP depletion
Source abstract
Abstract
ROS-responsive nanoparticles were designed to co-deliver the small molecule HIF-1α inhibitor Doxy and the photosensitizer IR780 for enhanced PDT efficiency.
Only a short abstract or summary was supplied by the source.
Source: crossref · Quality: short
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Cancer, Hypoxia, and Metabolism · Photodynamic Therapy Research Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety
CAS Center for Excellence in Nanoscience
National Center for Nanoscience and Technology
Beijing 100190
China
Department of Clinical Medicine
Zhongshan School of Medicine
Sun Yat-sen University
Guangzhou
College of Life Science and Bioengineering
Beijing University of Technology
Beijing 100124
P. R. China
Funding
National Natural Science Foundation of China
References (42)
Show source-provided references
1. Lovell · Chem. Rev. · 2010 · 110 · 283910.1021/cr900236h ↗
2. Zhou · Chem. Soc. Rev. · 2016 · 45 · 659710.1039/C6CS00271D ↗
3. Dolmans · Nat. Rev. Cancer · 2003 · 3 · 38010.1038/nrc1071 ↗
4. Wang · Mater. Chem. Front. · 2019 · 3 · 65010.1039/C9QM00036D ↗
5. Wang · ACS Appl. Bio Mater. · 2018 · 1 · 7010.1021/acsabm.8b00014 ↗
6. Lin · Theranostics · 2018 · 8 · 99010.7150/thno.22465 ↗
7. Cheng · Adv. Funct. Mater. · 2016 · 26 · 784710.1002/adfm.201603212 ↗
8. Cheng · Chem. Rev. · 2014 · 114 · 1086910.1021/cr400532z ↗
9. Wang · Chem. Commun. · 2018 · 54 · 1032810.1039/C8CC05560B ↗
10. Dai · Chem. Soc. Rev. · 2017 · 46 · 383010.1039/C6CS00592F ↗
11. Fan · Chem. Soc. Rev. · 2016 · 45 · 648810.1039/C6CS00616G ↗
12. Wilson · Nat. Rev. Cancer · 2011 · 11 · 39310.1038/nrc3064 ↗
13. Gallagher · Br. J. Cancer · 2005 · 92 · 170210.1038/sj.bjc.6602527 ↗
14. Cai · Nanoscale · 2018 · 10 · 2293710.1039/C8NR07679K ↗
15. Lv · Chem. Sci. · 2018 · 9 · 50210.1039/C7SC03765A ↗
16. Samanta · Cancer Res. · 2016 · 76 · 110.1158/0008-5472.1.76.1 ↗
17. Semenza · BBA, Biochim. Biophys. Acta, Mol. Cell Res. · 2016 · 1863 · 38210.1016/j.bbamcr.2015.05.036 ↗
18. Koyasu · Cancer Sci. · 2018 · 109 · 56010.1111/cas.13483 ↗
19. Kim · Cell Metab. · 2006 · 3 · 17710.1016/j.cmet.2006.02.002 ↗
20. Carmeliet · Nature · 1998 · 394
21. Chang · Cancer Lett. · 2017 · 403 · 2810.1016/j.canlet.2017.06.001 ↗
22. Jiang · J. Cell. Mol. Med. · 2018 · 22 · 437710.1111/jcmm.13732 ↗
23. Semenza · Trends Pharmacol. Sci. · 2012 · 33 · 20710.1016/j.tips.2012.01.005 ↗
24. Robey · Neoplasia · 2005 · 7 · 32410.1593/neo.04430 ↗
25. Lee · J. Biol. Chem. · 2003 · 278 · 3965310.1074/jbc.M306104200 ↗
26. Grandjean · Cancer Res. · 2016 · 76 · 425910.1158/0008-5472.CAN-16-0401 ↗
27. Taylor · Biochem. J. · 2008 · 409 · 1910.1042/BJ20071249 ↗
28. Singh · Mol. Pharmaceutics · 2016 · 13 · 208410.1021/acs.molpharmaceut.6b00206 ↗
29. Semenza · Curr. Pharm. Des. · 2009 · 15 · 383910.2174/138161209789649402 ↗
30. Francesco · Oncotarget · 2017 · 8 · 5612610.18632/oncotarget.18445 ↗
31. Lamb · Oncotarget · 2015 · 6 · 1400510.18632/oncotarget.4159 ↗
32. Um · Exp. Mol. Med. · 2004 · 36 · 23310.1038/emm.2004.32 ↗
33. Ahler · PLoS One · 2013 · 8 · 6456110.1371/journal.pone.0064561 ↗
34. Trachootham · Nat. Rev. Drug Discovery · 2009 · 8 · 57910.1038/nrd2803 ↗
35. Li · J. Controlled Release · 2017 · 251 · 4910.1016/j.jconrel.2017.02.020 ↗
36. Li · Chem. Commun. · 2018 · 54 · 1312710.1039/C8CC08445A ↗
37. Lv · Chem. Commun. · 2019 · 55 · 338310.1039/C9CC00358D ↗
38. Chen · J. Am. Chem. Soc. · 2018 · 140 · 737310.1021/jacs.7b12025 ↗
39. Zhang · Mater. Chem. Front. · 2017 · 1 · 80710.1039/C6QM00135A ↗
40. Wang · Chem. Mater. · 2018 · 30 · 348610.1021/acs.chemmater.8b01149 ↗
41. Dai · ACS Appl. Mater. Interfaces · 2019 · 11 · 1054010.1021/acsami.8b22748 ↗
42. Deng · J. Controlled Release · 2017 · 255 · 14210.1016/j.jconrel.2017.04.002 ↗